Skip to content

Clinical trials

Multiple Sclerosis trials in the United Arab Emirates

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Country / region: United Arab Emirates Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20111
20121
20161
20181
20221
20233
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Not yet recruiting3
Unknown status2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sheikh Shakhbout Medical City2
University of Sharjah2
Abu Dhabi Stem Cells Center1
Bayer1
Biogen1
EMD Serono Research & Development Institute, Inc.1
Hoffmann-La Roche1
MD Stem Cells1
New York University Abu Dhabi1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis13
Fatigue3
Multiple Sclerosis, Relapsing-Remitting2
Muscle Spasticity2
Alzheimer Disease1
Amyotrophic Lateral Sclerosis1
Ataxia1
Brain Injuries, Traumatic1
Brain Ischemia1
CADASIL1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.